Here, myCAFs in cholangiocarcinoma have been shown to secrete matricellular proteins like Periostin, growth factors like hepatocyte growth factor, and therefore activate pathways like PI3K/Akt or Hedgehog (Hh)-GLI [55], which leads to tumor progression and therapy resistance [56]. The gene discussed is AKT1; the disease is neoplasm.